Source: NewsOk

Paratek: Paratek: 2Q Earnings Snapshot

BOSTON (AP) _ Paratek Pharmaceuticals Inc. (PRTK) on Monday reported a loss of $23.1 million in its second quarter.The Boston-based company said it had a loss of 53 cents per share.The results did not meet Wall Street expectations.Read more on

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Evan Loh's photo - CEO of Paratek


Evan Loh

CEO Approval Rating


Paratek is a biopharmaceutical company that develops antibiotic drugs to treat bacterial pneumonia in adults. Read more